JOINN Releases 2025 AGM Circular: Profit Distribution Plan, Articles Amendments and 2026 Restricted A-Share Incentive Scheme Highlight Agenda

Bulletin Express
05/12

JOINN Laboratories (China) Co., Ltd. published a comprehensive circular on 13 May 2026 detailing matters to be tabled at its 2025 annual general meeting and the first H-share class meeting of 2026.

Key items in the circular:

1. 2025 Operating Documents • Release of the 2025 annual report and summary. • Review of the Board of Directors’ 2025 work report.

2. Capital Allocation • Proposal of the 2025 profit distribution plan; specific payout figures were not disclosed in the notice.

3. Governance Framework • Proposed amendments to the Articles of Association and to the Rules of Procedures of the General Meeting of Shareholders. • Proposed formulation of the Management Rules on Remuneration for Directors and Senior Management. • Proposal on overall director remuneration for the year.

4. Board Composition and Audit Oversight • Proposed appointment of a non-executive director. • Proposed re-appointment of the external auditors for 2026.

5. Equity Incentive Arrangements • Proposed adoption of the 2026 Restricted A-Share Incentive Scheme. • Proposed adoption of the associated Assessment Administrative Measures. • Proposed authorization for the Board to handle all matters related to the incentive plan.

6. Shareholder Meetings • Notice of the 2025 annual general meeting. • Notice of the first H-share class meeting of 2026. • Distribution of proxy forms for both meetings.

The full English and Chinese versions of the circular and related documents are now available on JOINN’s corporate website and on the Hong Kong Stock Exchange’s disclosure platform. Printed copies can be requested through Tricor Investor Services Limited, the company’s H-share registrar in Hong Kong, at no cost to shareholders who prefer hard copies.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10